Multi-Institution Prospective Trial of Reduced-Dose Craniospinal Irradiation (23.4 Gy) Followed by Conformal Posterior Fossa (36 Gy) and Primary Site Irradiation (55.8 Gy) and Dose-Intensive Chemotherapy for Average-Risk Medulloblastoma
Thomas E. Merchant, Larry E. Kun, Matthew J. Krasin, Dana Wallace, Murali M. Chintagumpala, Shiao Y. Woo, David M. Ashley, Maree Sexton, Stewart J. Kellie, Verity Ahern, Amar Gajjar
Dive into the research topics of 'Multi-Institution Prospective Trial of Reduced-Dose Craniospinal Irradiation (23.4 Gy) Followed by Conformal Posterior Fossa (36 Gy) and Primary Site Irradiation (55.8 Gy) and Dose-Intensive Chemotherapy for Average-Risk Medulloblastoma'. Together they form a unique fingerprint.